March is MS Awareness Month: Let’s Talk About Reducing the Cost of MS Care 🧡💙
For patients with multiple sclerosis (MS) who require long-term infusions like Ocrevus or Tysabri, traditional hospital-based treatment isn’t just expensive—it’s disruptive. Unnecessary drug markups, high facility fees, and missed workdays add up quickly, creating a financial burden for both patients and employers.
At Leap Health, we’re changing the model. By bringing MS infusions directly to patients at home, we eliminate inflated costs and improve access to care.
How Leap Health Saves Employers Money 💰
💊 Eliminating Drug Markups – Leap Health’s pass-through pricing model saves employers $51,000 annually per patient on average.
🏥 Reducing Site-of-Service Costs – Home infusion prevents hospital facility fees, which contribute to inflating costs by up to 500%.
📅 Improving Adherence – Missed infusions lead to worsening symptoms, hospitalizations, and long-term disability claims—we help patients stay on track.
👩💼 Enhancing Workforce Productivity – Traditional infusions take an entire day—Leap Health’s model cuts infusion time to two hours at home, helping patients return to work and daily activities sooner.
Why This Matters During MS Awareness Month
This March, we’re raising awareness about better, more affordable MS care. Employers have the opportunity to reduce costs, improve employee well-being, and eliminate unnecessary barriers to care.
💡 Want to learn how Leap Health is transforming MS care and saving employers millions?
Read our latest blog: 📖 https://bit.ly/4ijxntH
#MSAwarenessMonth #MultipleSclerosis #LeapHealth #HomeInfusion #CostSavings #EmployerBenefits #HealthcareInnovation #PatientCare